Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1992-07-10
1994-11-08
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
534 15, 534 16, 436173, 1286534, 514836, 514492, A61B 5055
Patent
active
053624750
ABSTRACT:
A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more Gadolinium ions and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
REFERENCES:
patent: 3663668 (1972-05-01), Grotenhuis
patent: 4957939 (1990-09-01), Gries et al.
patent: 5078986 (1992-01-01), Bosworth et al.
Yotsuya, M. et al. Chem. Abstracts 92(8):60289k (1979).
Waterman, W. J. et al. Chem. Abstracts 94(12):92622w (1980).
Ovitt et al., Improved Instrumentation Etc., NTIS No. PB82-118688, Sep. 1, 1979.
James J. Dechter & George C. Levy, "Aqueous Relaxation Reagents in Nitrogen-15 NMR", Journal of Magnetic Resonance 39, pp. 207-215 (1980).
Gmelin Handbuch der Anorganischen Chemie, Sc, Y, La-Lu Rare Earth Elements Part D1, Springer-Verlag, 1980.
Kniseley et al., J. of Nuclear Medicine, 7:575-582 (1966).
Hosain et al., "Ytterbium-169 Diethylenetriaminepentaacetic Acid Complex," Radiology, vol. 91, pp. 1199-1203 (Dec. 1968).
Forsberg et al., "Gmelin Handbuch der Anorganischen Chemie: Sc, Y, La-Lu, Rare Earth Elements," 8th Ed., Springer-Verlag, New York, pp. 198-204 (1980).
Dechter et al., J. of Magnetic Resonance, 39:207-215 (1980).
Durbin et al., "Metabolism of the Lanthanons in the Rat," Proc. Soc. Exp. Biol., 91:78-85 (1956).
Rubin et al., "Chelates as Possible Contrast Media," Annals New York Academy of Sciences, 78:764-778 (1959).
Sapeika, "Radiographic Use of Lead EDTA in Man," British Medical Journal, pp. 167-169 (Jul. 16, 1955).
Carson et al., "The Thermodynamics of the Formation of Complexes between Diethylenetriaminepentaacetic Acid and the Lanthanide Ions," J. Chem. Soc. (A), pp. 1384-1386 (1968).
James, Jr., et al., ".sub.169 Ytterbium Diethylenetriaminepentaacetic Acid (.sup.169 Yb DTPA)-A Versatile Radiopharmaceutical," Journal de l'Association Danadienne des Radiologistes, vol. 22, pp. 136-143 (Jun. 1971).
Graca et al., Arch. Environ. Health, 8:555-564 (Apr. 1964).
Graca et al., Arch. Environ. Health, 5:437-444 (Nov. 1962).
Ovitt et al., "Improved Instrumentation and Techniques for Non-Invasive Detection, Characterization and Quantification of Atherosclerosis for Research and Diagnostic Purposes," PB82-118688 (Sep. 1, 1979).
Gansow et al., J. Am. Chem. Soc., 94(7):2550-2552 (Apr. 5, 1972).
Finkbone, "Synthesis of Dysprosium-Diethylenetriaminepentaacetic Acid Salts and Investigation of their Acute Cardiotoxicity" (1979).
Moeller, Comprehensive Inorganic Chemistry, vol. 4, "44. The Lanthanides," pp. 1-101 (1980).
Kapitanova et al., Russian Journal of Inorganic Chemistry, 16(5):680-683 (1971).
Moeller et al., J. Inorg. Nucl. Chem., 24:499-510 (1962).
Gritmon et al., J. Inorg. Nucl. Chem., 39:2021-2023 (1977).
Choppin et al., J. Inorg. Nucl. Chem., 39:2025-2030 (1977).
Gansow et al., "A Shiftless Relaxation Reagent for Carbon-13 Magnetic Resonance of Organometallic Carbonyl Compounds," J.C.S. Chem. Comm., pp. 456-457 (1972).
Harder et al., J. Inorg. Nucl. Chem., 11:197-209 (1959).
Varlamova et al., Vestn. Mosk. Univ. Univ. Khim., 27:98-101 (1972).
Kruzhina et al., "The Formation of Complexes of Diethylenetriamine Pentaacetic Acid with Ions of Gadolinium and Lutecium," Zh. Fiz. Chim., 43:1196-1200 (1969).
The Condensed Chemical Dictionary, 10th ed., Hawley, pp. 881-882 (1981).
Gries Heinz
Hoyer Georg-Alexander
Mutzel Wolfgang
Pfeiffer, deceased Heinrich
Renneke Franz-Josef
Hollinden Gary E.
Schering Aktiengesellschaft
LandOfFree
Gadolinium chelates for magnetic resonance imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gadolinium chelates for magnetic resonance imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gadolinium chelates for magnetic resonance imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1780462